Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vaxcyte (PCVX) Gains from Investment Securities (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Gains from Investment Securities data on record, last reported at $9.3 million in Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 75.71% to $9.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $15.0 million, a 7.86% decrease, with the full-year FY2025 number at $11.0 million, down 23.1% from a year prior.
  • Gains from Investment Securities reached $9.3 million in Q1 2026 per PCVX's latest filing, up from $1.0 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for PCVX hit a ceiling of $9.3 million in Q3 2024 and a floor of -$7.4 million in Q4 2023.
  • A 5-year average of $2.0 million and a median of $1.8 million in 2022 define the central range for Gains from Investment Securities.
  • Peak YoY movement for Gains from Investment Securities: tumbled 200.6% in 2022, then skyrocketed 25331.76% in 2024.
  • Tracing PCVX's Gains from Investment Securities over 5 years: stood at -$6.5 million in 2022, then dropped by 13.53% to -$7.4 million in 2023, then surged by 114.61% to $1.1 million in 2024, then dropped by 7.19% to $1.0 million in 2025, then surged by 823.04% to $9.3 million in 2026.
  • Business Quant data shows Gains from Investment Securities for PCVX at $9.3 million in Q1 2026, $1.0 million in Q4 2025, and $4.0 million in Q3 2025.